Raphael Pharmaceutical (RAPH) EPS (Basic) (2020 - 2024)
Raphael Pharmaceutical (RAPH) reported EPS (Basic) of -$0.1 for Q4 2024, down 52.25% on a YoY basis from -$0.22 in Q1 2024, and down 506.53% sequentially from -$0.02 in Q3 2024.
Raphael Pharmaceutical (RAPH) EPS (Basic) (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of EPS (Basic) data on file, last reported at -$0.1 in Q4 2024.
- For the quarter ending Q4 2024, EPS (Basic) fell 52.25% year-over-year to -$0.1; the trailing twelve-month figure through Sep 2025 stood at -$0.1 (up 18.22% YoY), and the FY2025 full-year result was -$0.17, down 1.31% from the prior year.
- EPS (Basic) fell to -$0.1 in Q4 2024, from -$0.02 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q2 2024 to a low of -$0.16 in Q4 2021.
- A 5-year average of -$0.05 and a median of -$0.04 in 2021 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 299.61% in 2021 and surged 61.52% in 2024, its largest moves.
- Tracing RAPH's EPS (Basic) over 5 years: stood at -$0.04 in 2020, then sank by 299.61% to -$0.16 in 2021, then gained by 21.5% to -$0.13 in 2022, then jumped by 46.77% to -$0.07 in 2023, then slumped by 52.25% to -$0.1 in 2024.
- Business Quant data shows RAPH's EPS (Basic) at -$0.1 in Q4 2024, -$0.02 in Q3 2024, and -$0.01 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.13 |
| Sep 30, 2022 | -0.09 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.04 |
| Mar 31, 2021 | -0.03 |
| Dec 31, 2020 | -0.04 |